New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Humacyte, Inc.
HUMA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

679M

Biotechnology

Next Earning date - 14 Nov 2024

679M

Biotechnology

Next Earning date - 14 Nov 2024

5.42USD
Shape-0.17 ( -3.04%)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-12%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

46%

Quote Panel

Shape
Updated October 29, 2024
1W -5.24 % 1M -0.37 % 3M -33.90 % 1Y 165.69 %

Key Metrics

Shape
  • Market Cap

    678.63M


  • Shares Outstanding

    125.21M


  • Share in Float

    97.86M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    5.42


  • Average Volume

    3.04M


  • Beta

    1.452


  • Range

    1.96-9.97


  • Industry

    Biotechnology


  • Website

    https://www.humacyte.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

62.89x

P/S Ratio

-22.83x

P/B Ratio

-0.6

Debt/Equity

-1294.3%

Net Margin

$-1.3

EPS

How HUMA compares to sector?

P/E Ratio

Relative Strength

Shape

HUMA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$18M

ShapeNaN%

2025-Revenue

$0.82

Shape-70%

2025-EPS

$11M

Shape60%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

EF Hutton

initialise

Previous: Not converted

2024-09-09

Now: Buy

Piper Sandler

upgrade

Previous: Not converted

2023-08-14

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.25
vs -0.72

Q4.22

arrow
arrow

N/A

-0.21
vs -0.22

Q1.23

arrow
arrow

N/A

-0.22
vs -0.22

Q2.23

arrow
arrow

N/A

-0.22
vs -0.19

Q3.23

arrow
arrow

N/A

-0.25
vs -0.25

Q4.23

arrow
arrow

N/A

-0.24
vs -0.21

Q1.24

arrow
arrow

N/A

-0.29
vs -0.22

Q2.24

arrow
arrow

N/A

-0.27
vs -0.22

Q3.24

arrow
arrow

N/A

-0.25
vs -0.25

Q4.24

arrow
arrow

N/A

-0.24
vs -0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-87%

31K  vs 241K

Q4.22

arrow
arrow

-100%

NA  vs 177K

Q1.23

arrow
arrow

-100%

NA  vs 233K

Q2.23

arrow
arrow

-100%

NA  vs 1.3M

Q3.23

arrow
arrow

-100%

NA  vs 31K

Q4.23

arrow
arrow

NA

10.8M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

300K  vs NA

Q4.24

arrow
arrow

-97%

350K  vs 10.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-21%

-0.21
vs 0.26

Q4.22

arrow
arrow

+12%

0.12
vs -0.21

Q1.23

arrow
arrow

-76%

-0.76
vs 0.12

Q2.23

arrow
arrow

-37%

-0.37
vs -0.76

Q3.23

arrow
arrow

-70%

-0.70
vs -0.37

Q4.23

arrow
arrow

-185%

-1.85
vs -0.70

Q1.24

arrow
arrow

-122%

-1.22
vs -1.85

Q2.24

arrow
arrow

+200%

2
vs -1.22

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

74

74
vs 79

-6%

Q4.22

arrow
arrow

75

75
vs 74

1%

Q1.23

arrow
arrow

69

69
vs 75

-8%

Q2.23

arrow
arrow

77

77
vs 69

12%

Q3.23

arrow
arrow

86

86
vs 77

12%

Q4.23

arrow
arrow

90

90
vs 86

5%

Q1.24

arrow
arrow

101

101
vs 90

12%

Q2.24

arrow
arrow

129

129
vs 101

28%

Earnings Growth

Latest News